ZH

RU

ES

biological evaluation

biological evaluation, Total:498 items.

In the international standard classification, biological evaluation involves: Laboratory medicine, Medical equipment, Pesticides and other agrochemicals, Pharmaceutics, Dentistry, Microbiology, Medical sciences and health care facilities in general, Hospital equipment, Information sciences. Publishing, Aerosol containers.


未注明发布机构, biological evaluation

  • DIN EN ISO 10993-18:2009 Biological assessment of medical devices
  • DIN EN ISO 10993-1:2003 Biological assessment of medical devices Part 1: Assessment and testing
  • DIN EN ISO 10993-1:1998 Biological evaluation of medical devices – Part 1: Evaluation and testing
  • BS EN ISO 10993-11:2018(2022) Biological evaluation of medical devices Part 11 : Tests for systemic toxicity
  • YY 0127.7-2017 Biological Evaluation of Oral Medical Devices Part 7: Pulp Dentin Application Test
  • BS EN ISO 10993-1:2020 Tracked Changes. Biological evaluation of medical devices. Evaluation and testing within a risk management process
  • YY 0127.8-2001 Biological evaluation of oral materials. Unit 2: Biological testing methods of oral materials. Subcutaneous implantation test
  • YY 0127.6-1999 Biological evaluation of oral materials. Unit 2: Biological testing methods of oral materials. Manifest lethality test
  • BS EN ISO 10993-16:2017(2020) Biological evaluation of medical devices Part 16 : Toxicokinetic study design for degradation products and leachables
  • ISO 10993-15:2000/Cor 1:2001 Biologicalevaluation of medical devices - Part 15: Identificationand quantification of degradation products from metals and alloys

International Organization for Standardization (ISO), biological evaluation

  • ISO/TR 15499:2016 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO/TR 7405:1984 Biological evaluation of dental materials
  • ISO/TR 15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO 10993-1:2003 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • ISO 11930:2019 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product
  • ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • ISO 10993-2:2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • ISO 10993-2:1992 Biological evaluation of medical devices; part 2: animal welfare requirements
  • ISO 10993-2:2022 Biological evaluation of medical devices — Part 2: Animal welfare requirements
  • ISO 10993-11:1993 Biological evaluation of medical devices; part 11: tests for systemic toxicity
  • ISO 10993-10:2021 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • ISO 10993-8:2000 Biological evaluation of medical devices - Part 8: Selection and qualification of reference materials for biological tests
  • ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices — Part 1: General requirements
  • ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-11:2017 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO 10993-12:2021 Biological evaluation of medical devices — Part 12: Sample preparation and reference materials
  • ISO 10993-6:1994 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • ISO 10993-7:1995 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-7:2008 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-6:2016 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • ISO 10993-5:1992 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO/TR 10993-55:2023 Biological evaluation of medical devices — Part 55: Interlaboratory study on cytotoxicity
  • ISO 10993-14:2001 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • ISO 10993-1:2009/Cor 11:2010 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
  • ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 10993-4:1992 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood
  • ISO 10993-18:2020/Amd 1:2022 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood
  • ISO/CD TR 37137-2 Biological evaluation of absorbable medical devices — Part 2: Standard guide for absorbable metals
  • ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
  • ISO 10993-7:2008/cor 1:2009 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals; Technical Corrigendum 1
  • ISO 10993-3:1992 Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ISO 10993-9:2009 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-9:1999 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-9:2019 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-15:2000 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys
  • ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-13:1998 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices

国家食品药品监督管理局, biological evaluation

  • YY/T 1512-2017 Implementation Guidelines for Biological Evaluation in the Risk Management Process of Biological Evaluation of Medical Devices
  • YY/T 1532-2017 Medical device biological evaluation nanomaterials hemolysis test
  • YY/T 0127.13-2018 Biological evaluation of oral medical devices Part 13: Oral mucosal irritation test
  • YY/T 0127.7-2017 Biological Evaluation of Oral Medical Devices Part 7: Pulp Dentin Application Test
  • YY/T 1535-2017 Biological evaluation of medical devices for human in vitro assisted reproductive technology and human sperm survival test
  • YY/T 0719.7-2011 Ophthalmic optical contact lenses and contact lens care products - Part 7: Test methods for biological evaluation
  • YY/T 0127.15-2018 Biological Evaluation of Oral Medical Devices Part 15: Subacute and Subchronic Systemic Toxicity Tests: Oral Route

US-AAMI, biological evaluation

  • ANSI/AAMI/ISO TIR15499:2012 Biological evaluation of medical devices - Guideance on the conduct of biological evaluation within a risk management process
  • ANSI/AAMI/ISO 10993-1:2009 Biological evaluation of medical devices - Part 1:Evaluation and testing within a risk management process
  • ANSI/AAMI/ISO 10993-3:2014 Biological evaluation of medical devices. Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ANSI/AAMI/ISO 10993-16:2017 Biological evaluation of medical devices-Part 16: Toxicokinetic study design for degradation products and leachables

British Standards Institution (BSI), biological evaluation

  • BS PD ISO/TR 15499:2016 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • BS EN ISO 10993-2:2022 Biological evaluation of medical devices - Animal welfare requirements
  • PD ISO/TR 10993-22:2017 Biological evaluation of medical devices. Guidance on nanomaterials
  • BS PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • BS EN ISO 10993-12:2012 Biological evaluation of medical devices. Sample preparation and reference materials
  • BS EN ISO 10993-11:2018 Biological evaluation of medical devices. Tests for systemic toxicity
  • BS EN ISO 10993-6:2009 Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-10:2010 Biological evaluation of medical devices. Tests for irritation and skin sensitization
  • BS EN ISO 10993-10:2023 Tracked changes. Biological evaluation of medical devices. Tests for skin sensitization
  • PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • PD ISO/TR 10993-55:2023 Biological evaluation of medical devices. Interlaboratory study on cytotoxicity
  • BS PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • BS EN ISO 10993-14:2009 Biological evaluation of medical devices - Identification and quantification of degradation products from ceramics
  • BS EN ISO 10993-17:2009 Biological evaluation of medical devices. Establishment of allowable limits for leachable substances
  • BS EN ISO 10993-7:2008+A1:2022 Tracked Changes. Biological evaluation of medical devices. Ethylene oxide sterilization residuals
  • PD ISO/TS 10993-19:2020 Biological evaluation of medical devices. Physico-chemical, morphological and topographical characterization of materials
  • BS EN ISO 10993-6:2016 Tracked Changes. Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-12:2021 Tracked Changes. Biological evaluation of medical devices. Sample preparation and reference materials
  • BS EN 29073-3:1992 Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
  • BS EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11:Tests for systemic toxicity (ISO 10993-11:2006)
  • 19/30372368 DC BS EN ISO 10993-23. Biological evaluation of medical devices. Part 23. Tests for irritation
  • 20/30398724 DC BS EN ISO 10993-2. Biological evaluation of medical devices. Part 2. Animal welfare requirements
  • DD ISO/TS 10993-20:2006 Biological evaluation of medical devices. Principles and methods for immunotoxicology testing of medical devices
  • 20/30377819 DC BS EN ISO 10993-10. Biological evaluation of medical devices. Part 10. Tests for skin sensitization
  • BS EN ISO 10993-16:2017 Biological evaluation of medical devices - Toxicokinetic study design for degradation products and leachables
  • BS EN ISO 10993-13:2010 Biological evaluation of medical devices. Part 13: Identification and quantification of degradation products from polymeric medical devices
  • PD ISO/TR 10993-33:2015 Biological evaluation of medical devices. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • BS EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
  • 22/30427685 DC BS EN 455-3. Medical gloves for single use. Part 3. Requirements and testing for biological evaluation
  • BS EN ISO 10993-3:2014 Biological evaluation of medical devices. Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • 16/30343252 DC BS EN 455-3 AMD1. Medical gloves for single use. Part 3. Requirements and testing for biological evaluation
  • BS EN ISO 10993-9:2021 Tracked Changes. Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
  • PD ISO/TR 15499:2016 Tracked Changes. Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • 18/30355036 DC BS EN ISO 10993-7 AMD1. Biological evaluation of medical devices - Part 7. Ethylene oxide sterilization residuals
  • 19/30376763 DC BS EN ISO 10993-12. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • 21/30379304 DC BS EN ISO 10993-17. Biological evaluation of medical devices - Part 17. Toxicological risk assessment of medical device constituents
  • PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • 17/30344601 DC BS EN ISO 10993-1. Biological evaluation of medical devices. Part 1. Evaluation and testing within a risk management process
  • 18/30354689 DC BS EN ISO 10993-9. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • 18/30354781 DC BS EN ISO 10993-15. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys

ZA-SANS, biological evaluation

  • SANS 5233:2007 Pesticides - Biological evaluation of the efficacy of mists and fogs
  • SANS 5695:1978 Pesticides: Biological evaluation of the efficacy of mosquito repellants
  • SANS 5694:2007 Pesticides - Biological testing of the efficacy of rodenticides
  • SANS 192:1978 Pesticides: Biological evaluation of the efficacy of molluscicides
  • SANS 5693:2007 Pesticides - Biological evaluation of the efficacy of insecticide dusting powders
  • SANS 10993-1:2003 Biological evaluation of medical devices Part 1: Evaluation and testing
  • SANS 5690:2003 Pesticides - Biological evaluation of the properties of solid fly baits
  • SANS 5471:2006 Pesticides - Biological evaluation of the resistance of materials to termite attack
  • SANS 5823:1978 Pesticides: Biological evaluation of the efficacy of insecticides used on compost
  • SANS 6136:2003 Pesticides - Biological evaluation of materials that release an insecticide upon heating
  • SANS 10993-5:2003 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
  • SANS 5422:2007 Pesticides - Biological evaluation of insecticidal sprays on compost (laboratory test)
  • SANS 5824:1978 Pesticides: Biological evaluation of powders that prevent decay and inhibit sprout formation in potatoes
  • SANS 5689:2002 Pesticides - Biological evaluation of knock-down and killing properties of liquid and aerosol formulations
  • SANS 5580:1969 Pesticides: Biological evaluation of mothproof textiles containing wool
  • SANS 5327:1978 Pesticides: Comparative biological evaluation of the susceptibility of two strains of house-flies to insecticides
  • SANS 5581:1978 Pesticides: Biological evaluation of wash-durability properties of mothproof textiles containing wool
  • SANS 10993-4:2004 Biological evaluation of medical devices Part 4: Selection of tests for interactions with blood
  • SANS 5858:2007 Pesticides - Biological evaluation of mosquito larvicides in artificially created mosquito breeding places
  • SANS 5857:1976 Pesticides: Biological evaluation of mothproof textiles containing wool after exposure to artificial sunlight
  • SANS 5582:1978 Pesticides: Biological evaluation of dry-cleaning-durability properties of mothproof textiles containing wool
  • SANS 5696:1978 Pesticides: Biological evaluation of the efficacy of residual sprays against skin and hide beetles
  • SANS 10993-10:2004 Biological evaluation of medical devices Part 10: Tests for irritation and delayed-type hypersensitivity
  • SANS 10993-3:2004 Biological evaluation of medical devices Part 3: Test for genotoxicity, carcinogenicity and reproductive toxicity
  • SANS 5576:2003 Pesticides - Biological evaluation of the efficacy of insecticidal water-based and oil-based space sprays in low pressurized dispensers

Association Francaise de Normalisation, biological evaluation

  • NF S99-501:1998 Biological evaluation of medical devices. Part 1 : evaluation and testing.
  • NF EN ISO 10993-23:2021 Evaluation biologique des dispositifs médicaux - Partie 23 : essais d'irritation
  • NF S99-501-23*NF EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23 : tests for irritation
  • NF EN ISO 10993-11:2018 Évaluation biologique des dispositifs médicaux - Partie 11 : essais de toxicité systémique
  • NF EN ISO 10993-10:2023 Évaluation biologique des dispositifs médicaux - Partie 10 : essais de sensibilisation cutanée
  • NF S99-501-11:2009 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity.
  • NF S99-501-11*NF EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity
  • FD S99-501-22*FD ISO/TR 10993-22:2017 Biological evaluation of medical devices - Part 22 : guidance on nanomaterials
  • FD ISO/TR 10993-22:2017 Évaluation biologique des dispositifs médicaux - Partie 22 : lignes directrices sur la nanomatériaux
  • NF S99-501-18:2009 Biological evaluation of medical devices - Part 18 : chemical characterization of materials.
  • FD S99-516*FD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • NF EN ISO 10993-2:2022 Évaluation biologique des dispositifs médicaux - Partie 2 : Exigences relatives à la protection des animaux
  • NF EN ISO 10993-5:2010 Évaluation biologique des dispositifs médicaux - Partie 5 : essais concernant la cytotoxicité in vitro
  • NF S99-507:1996 Biological evaluation of medical devices. Part 7 : ethylene oxide sterilization residuals.
  • NF EN ISO 10993-7:2008 Évaluation biologique des dispositifs médicaux - Partie 7 : résidus de stérilisation à l'oxyde d'éthylène
  • NF S99-501-5*NF EN ISO 10993-5:2010 Biological evaluation of medical devices - Part 5 : tests for in vitro cytotoxicity.
  • NF EN ISO 10993-6:2017 Évaluation biologique des dispositifs médicaux - Partie 6 : essais concernant les effets locaux après implantation
  • NF EN ISO 10993-17:2009 Évaluation biologique des dispositifs médicaux - Partie 17 : établissement des limites admissibles des substances relargables
  • NF EN ISO 10993-12:2021 Evaluation biologique des dispositifs médicaux - Partie 12 : préparation des échantillons et matériaux de référence
  • NF S99-501-12:2012 Biological evaluation of medical devices - Part 12 : sample preparation and reference materials.
  • NF S99-501-12*NF EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12 : sample preparation and reference materials
  • NF S99-506:1995 Biological evaluation of medical devices. Part 6 : tests for local effects after implantation.
  • NF S99-501-10*NF EN ISO 10993-10:2013 Biological evaluation of medical devices - Part 10 : tests for irritation and skin sensitization
  • NF EN ISO 10993-14:2009 Évaluation biologique des dispositifs médicaux - Partie 14 : identification et quantification des produits de dégradation des céramiques
  • XP ISO/TS 10993-19:2022 Évaluation biologique des dispositifs médicaux - Partie 19 : caractérisations physicochimique, morphologique et topographique des matériaux
  • NF EN ISO 10993-3:2014 Évaluation biologique des dispositifs médicaux - Partie 3 : essais concernant la génotoxicité, la cancérogénicité et la toxicité sur la reproduction
  • NF S99-504:1994 Biological evaluation of medical devices. Part 4 : selection of tests for interactions with blood.
  • NF S99-501-4*NF EN ISO 10993-4:2018 Biological evaluation of medical devices - Part 4 : selection of tests for interactions with blood
  • NF EN ISO 10993-4:2018 Évaluation biologique des dispositifs médicaux - Partie 4 : choix des essais pour les interactions avec le sang
  • NF EN 455-3:2015 Gants médicaux non réutilisables - Partie 3 : exigences et essais pour évaluation biologique
  • NF EN ISO 10993-7/A1:2022 Evaluation biologique des dispositifs médicaux - Partie 7 : résidus de stérilisation à l'oxyde d'éthylène - Amendement 1
  • NF S99-501-3:2009 Biological evaluation of medical devices - Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity.
  • NF S99-501-3*NF EN ISO 10993-3:2014 Biological evaluation of medical devices - Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity
  • NF S99-503:1994 Biological evaluation of medical devices. Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity.
  • NF S99-501-9*NF EN ISO 10993-9:2021 Biological evaluation of medical devices - Part 9 : framework for identification and quantification of potential degradation products
  • NF EN ISO 10993-9:2021 Evaluation biologique des dispositifs médicaux - Partie 9 : cadre pour l'identification et la quantification des produits potentiels de dégradation
  • NF S99-501-15*NF EN ISO 10993-15:2009 Biological evaluation of medical devices - Part 15 : identification and quantification of degradation products from metals and alloys
  • NF EN ISO 10993-15:2009 Évaluation biologique des dispositifs médicaux - Partie 15 : identification et quantification des produits de dégradation issus des métaux et alliages
  • NF EN ISO 10993-13:2010 Évaluation biologique des dispositifs médicaux - Partie 13 : identification et quantification de produits de dégradation de dispositifs médicaux à base de polymères
  • NF EN ISO 10993-16:2017 Évaluation biologique des dispositifs médicaux - Partie 16 : conception des études toxicocinétiques des produits de dégradation et des substances relargables
  • NF EN 60335-2-95:2017 Évaluation biologique des dispositifs médicaux - Partie 16 : conception des études toxicocinétiques des produits de dégradation et des substances relargables
  • NF S99-501-13*NF EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13 : identification and quantification of degradation products from polymeric medical devices
  • NF S99-501-16*NF EN ISO 10993-16:2017 Biological evaluation of medical devices - Part 16 : Toxicokinetic study design for degradation products and leachables
  • NF S99-501-18*NF EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18 : chemical characterization of medical device materials within a risk management process
  • NF S99-501-16:2010 Biological evaluation of medical devices - Part 16 : toxicokinetic study design for degradation products and leachables.

General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China, biological evaluation

  • GB/T 16175-2008 Biological evaluation test methods for medical organic silicon materials
  • GB/T 16175-1996 Organic silicon material for medical use--Biological evaluation test methods
  • GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1: Evaluation and testing
  • GB/T 16886.18-2011 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2: Animal welfare requirements
  • GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • GB/T 16886.11-1997 Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
  • GB/Z 16886.22-2022 Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
  • GB/T 16886.11-2011 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • GB/T 16886.10-2000 Biological evaluation of medical devices--Part 10: Tests for irritation and sensitization
  • GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests
  • GB/T 16886.5-2003 Biological evaluation of medical devices--Part 5: Test for in vitro cytotoxicity
  • GB/T 16886.12-2005 Biological evaluation of medical devices-Part 12:Sample preparation and reference materials
  • GB/T 16886.6-2015 Biological evaluation of medical devices.Part 6:Tests for local effects after implantation
  • GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals
  • GB/T 16886.12-2000 Biological evaluation of medical devices--Part 12: Sample preparation and reference materials
  • GB/T 16886.7-2001 Biological evaluation of medical devices--Part 7:Ethylene oxide sterilization residuals
  • GB/T 16886.6-1997 Biological evaluation of medical devices--Part 6: Tests for local effects after implantation
  • GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances
  • GB/T 16886.1-2011 Biological evaluation of medical devices.Part 1: Evaluation and testing within a risk management process
  • GB/T 16886.4-2003 Biological evaluation of medical devices--Part 4: Selection of tests for interactions with blood
  • GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics
  • GB/T 16886.10-2005 Biological evaluation of medical devices.Part 10:Tests for irritation and delayed-type hypersensitivity
  • GB/T 16886.3-2008 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.3-1997 Biological evaluation of medical devices--Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products
  • GB/T 16886.9-2001 Biological evaluation of medical devices-Part 9:Framework for identification and quantification of potential degradation product
  • GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
  • GB/T 16886.19-2011 Biological evaluation of medical devices.Part 19: Physico-chemical,morphological and topographical characterization of materials
  • GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys
  • GB/T 16886.15-2003 Biological eveluation of medical devices--Part 15: Identification and quantification of degradation products from metals and alloys
  • GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices
  • GB/T 16886.16-2013 Biological evaluation of medical devices.Part 16: Toxicokinetic study design for degradation products and leachables
  • GB/T 16886.16-2003 Biological evaluation of medical devices--Part 16: Toxicokinetic study design for degradation products and leachables
  • GB/T 16886.13-2001 Biological evaluation of medical devices--Part 13:Identification and quantification of degradation products from polymeric medical devices
  • GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process

Group Standards of the People's Republic of China, biological evaluation

  • T/CAMDI 033-2020 Guide for biological evaluation of packaging materials for medical devices
  • T/CAMDI 034-2020 Biological evaluation of medical devices Medical catheter with hydrophilic polymer coating:Sample preparation

Standard Association of Australia (SAA), biological evaluation

VN-TCVN, biological evaluation

  • TCVN 7391-1-2004 Biological evaluation of medical devices.Part 1: Evaluation and testing
  • TCVN 7391-18-2007 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • TCVN 7391-2-2005 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • TCVN 7391-11-2007 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • TCVN 7391-5-2005 Biological evaluation of medical devices.Part 5: Tests for in vitro cytotoxicity
  • TCVN 7391-12-2007 Biological evaluation of medical devices.Part 12: Sample preparation and reference materials
  • TCVN 7391-6-2007 Biological evaluation of medical devices.Part 6: Tests for local effects after implantation
  • TCVN 7391-7-2004 Biological evaluation of medial devices.Part 7: Etylen oxide sterilization residuals
  • TCVN 7391-17-2007 Biological evaluation of medical devices.Part 17: Establishment of allowable limits for teachable substances
  • TCVN 7391-10-2007 Biological evaluation of medical devices.Part 10: Tests for irritation and delayed-type hypersensitivity
  • TCVN 7391-4-2005 Biological evaluation of medical devices.Part 4: Selection of test for interactions with blood
  • TCVN 7391-14-2007 Biological evaluation of medical devices.Part 14: Identification and quantification of degradation products from ceramics
  • TCVN 7391-3-2005 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • TCVN 7391-15-2007 Biological evaluation of medical devices.Part 15: Identification and quantification of degradation products from metals and alloys
  • TCVN 7391-16-2007 Biological evaluation of medical devices.Part 16: Toxicokinetic study design for degradation products and leachables

TH-TISI, biological evaluation

  • TIS 2395.1-2008 Biological evaluation of medical devices.part 1: evaluation and testing
  • TIS 2395.18-2008 Biological evaluation of medical devices.part 18: chemical characterization of materials
  • TIS 2395.11-2008 Biological evaluation of medical devices.part 11: tests for systemic toxicity
  • TIS 2395.2-2008 Biological evaluation of medical devices.part 2: animal welfare requirements
  • TIS 2395.5-2008 Biological evaluation of medical devices.part 5: tests for in vitro cytotoxicity
  • TIS 2395.6-2008 Biological evaluation of medical devices.part 6: tests for local effects after implantation
  • TIS 2395.7-2008 Biological evaluation of medical devices.part 7: ethylene oxide sterilization residuals
  • TIS 2395.12-2008 Biological evaluation of medical devices.part 12: sample preparation and reference materials
  • TIS 2395.4-2008 Biological evaluation of medical devices.part 4: selection of tests for interactions with blood
  • TIS 2395.14-2008 Biological evaluation of medical devices.part 14: identification and quantification of degradation products from ceramics
  • TIS 2395.17-2008 Biological evaluation of medical devices.part 17: establishment of allowable limits for leachable substances
  • TIS 2395.3-2008 Biological evaluation of medical devices.part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity
  • TIS 2395.10-2008 Biological evaluation of medical devices.part 10: tests for irritation and delayed-type hypersensitivity
  • TIS 2395.9-2008 Biological evaluation of medical devices.part 9: framework for identification and quantification of potential degradation products
  • TIS 2395.15-2008 Biological evaluation of medical devices.part 15: identification and quantification of degradation products from metals and alloys
  • TIS 2395.16-2008 Biological evaluation of medical devices.part 16: toxicokinetic study design for degradation products and leachables
  • TIS 2395.13-2008 Biological evaluation of medical devices.part 13: identification and quantification of degradation products from polymeric medical devices

Korean Agency for Technology and Standards (KATS), biological evaluation

  • KS P ISO TS 20993-2009(2014) Biological evaluation of medical devices-Guidance on a risk-management process
  • KS M ISO 11930:2020 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product
  • KS P ISO 10993-2-2010(2021) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-2-2010(2016) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-11-2007(2017) Biological evaluation of medical devices-Part 11:Tests for systemic toxicity
  • KS P ISO 10993-18-2009(2019) Biological evaluation of medical devices-Part 18:Chemical characterization of materials
  • KS P ISO 10993-11:2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO 10993-8:2002 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-8:2007 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-7:2017 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO 10993-4:2017 Biological evaluation of medical devices-Part 4:Selection of tests for interactions with blood
  • KS P ISO 10993-19-2009(2019) Biological evaluation of medical devices-Part 19:Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-4:2021 Biological evaluation of medical devices —Part 4: Selection of tests for interactions with blood
  • KS P ISO TS 10993-19:2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-15-2006(2016) Biological evaluation of medical devices-Part 15:Identification and quantification ofdegradation products from metals and alloys
  • KS P ISO 10993-9:2021 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products
  • KS P ISO 10993-20-2009(2019) Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
  • KS P ISO 10993-15:2021 Biological evaluation of medical devices — Part 15: Identification and quantification of degradation products from metals and alloys
  • KS P ISO 10993-16:2017 Biological evaluation of medical devices — Part16:Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-16:2021 Biological evaluation of medical devices —Part 16: Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-18:2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process

Japanese Industrial Standards Committee (JISC), biological evaluation

  • JIS T 0993-1:2005 Biological evaluation of medical devices -- Part 1: Evaluation and testing
  • JIS T 0993-7:2012 Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals
  • JIS T 0993-1:2012 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

CEN - European Committee for Standardization, biological evaluation

  • EN ISO 11930:2012 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product
  • EN ISO 11930:2019 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product
  • EN ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-6:2009 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • EN ISO 10993-6:2007 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • EN ISO 10993-14:2001 Biological Evaluation of Medical Devices - Part 14: Identification and Quantification of Degradation Products from Ceramics
  • EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • EN ISO 10993-9:2021 Biological Evaluation of Medical Devices - Part 9: Framework for Identification and Quantification of Potential Degradation Products
  • EN ISO 10993-9:1999 Biological Evaluation of Medical Devices - Part 9: Framework for Identification and Quantification of Potential Degradation Products
  • EN ISO 10993-9:2009 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products

KR-KS, biological evaluation

  • KS M ISO 11930-2020 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product
  • KS P ISO 10993-23-2022 Biological evaluation of medical devices — Part 23: Tests for irritation
  • KS P ISO 10993-11-2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO 10993-10-2022 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • KS P ISO 10993-8-2002 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-7-2017 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO 10993-7-2022 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals
  • KS P ISO 10993-14-2017 Biological evaluation of medical devices — Part14:Identification and quantification of degradation products from ceramics
  • KS P ISO 10993-4-2017 Biological evaluation of medical devices-Part 4:Selection of tests for interactions with blood
  • KS P ISO 10993-14-2017(2022) Biological evaluation of medical devices — Part14:Identification and quantification of degradation products from ceramics
  • KS P ISO 10993-4-2021 Biological evaluation of medical devices —Part 4: Selection of tests for interactions with blood
  • KS P ISO TS 10993-19-2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-9-2021 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products
  • KS P ISO 10993-15-2021 Biological evaluation of medical devices — Part 15: Identification and quantification of degradation products from metals and alloys
  • KS P ISO 10993-16-2017 Biological evaluation of medical devices — Part16:Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-16-2021 Biological evaluation of medical devices —Part 16: Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-18-2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process

Danish Standards Foundation, biological evaluation

  • DS/ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation
  • DS/ISO/TR 10993-22:2021 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
  • DS/ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices – Part 1: General requirements
  • DS/ISO 10993-12:2021 Biological evaluation of medical devices – Part 12: Sample preparation and reference materials
  • DS/EN ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation (ISO 10993-23:2021)
  • DS/EN ISO 10993-12:2012 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • DS/EN 455-3:2007 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation
  • DS/EN ISO 10993-12:2021 Biological evaluation of medical devices – Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • DS/ISO 10993-9:2021 Biological evaluation of medical devices – Part 9: Framework for identification and quantification of potential degradation products
  • DS/ISO 10993-1:2020 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process (ISO/FDIS 10993-1:2018)
  • DS/EN ISO 10993-9:2021 Biological evaluation of medical devices – Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)
  • DS/EN ISO 10993-1:2020 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-11)

German Institute for Standardization, biological evaluation

  • DIN EN ISO 10993-2:2023-02 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022); German version EN ISO 10993-2:2022
  • DIN EN ISO 10993-10:2023-04 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021); German version EN ISO 10993-10:2023
  • DIN EN ISO 10993-11:2018-09 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017); German version EN ISO 10993-11:2018
  • DIN EN ISO 10993-5:2009-10 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009); German version EN ISO 10993-5:2009
  • DIN EN ISO 10993-6:2017-09 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016); German version EN ISO 10993-6:2016
  • DIN EN ISO 10993-12:2021-08 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021); German version EN ISO 10993-12:2021
  • DIN EN 455-3:2022-03 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation; German and English version prEN 455-3:2022 / Note: Date of issue 2022-02-04*Intended as replacement for DIN EN 455-3 (2015-07).
  • DIN EN ISO 10993-23:2021-10 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021); German version EN ISO 10993-23:2021
  • DIN EN ISO 10993-2:2023 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • DIN EN ISO 10993-17:2021-12 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021 / Note: Date of issue 2021-11-12*Intended as replacement for DIN...
  • DIN EN 455-3:2022 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation; German and English version prEN 455-3:2022
  • DIN EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
  • DIN EN ISO 10993-10:2023 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021)
  • DIN EN 455-3:2015-07 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation; German version EN 455-3:2015 / Note: To be replaced by DIN EN 455-3 (2022-03).*To be amended by DIN EN 455-3/A1 (2016-11).
  • DIN EN ISO 10993-23:2019 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO/DIS 10993-23:2019); German and English version prEN ISO 10993-23:2019
  • DIN EN ISO 10993-14:2009-08 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001); German version EN ISO 10993-14:2009 / Note: DIN EN ISO 10993-14 (2002-05) remains valid alongside this stan...
  • DIN EN ISO 10993-17:2009-08 Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002); German version EN ISO 10993-17:2009 / Note: DIN EN ISO 10993-17 (2003-06) remains valid alongside this standard until 20...
  • DIN EN ISO 10993-1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management system (ISO 10993-1:2009); German version EN ISO 10993-1:2009
  • DIN EN ISO 10993-3:2015-02 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014); German version EN ISO 10993-3:2014
  • DIN EN ISO 10993-12:2019 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO/DIS 10993-12:2019); German and English version prEN ISO 10993-12:2019
  • DIN EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001)
  • DIN EN ISO 10993-1:2017 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO/DIS 10993-1:2017); German and English version prEN ISO 10993-1:2017
  • DIN EN ISO 10993-16:2018-02 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017); German version EN ISO 10993-16:2017
  • DIN EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021); German version EN ISO 10993-23:2021
  • DIN EN ISO 10993-4:2017-12 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017); German version EN ISO 10993-4:2017
  • DIN EN ISO 10993-9:2010 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2009)
  • DIN EN ISO 10993-7:2022-09 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008 + Cor 1:2009 + Amd 1:2019); German version EN ISO 10993-7:2008 + AC:2009 + A1:2022
  • DIN EN ISO 10993-9:2018 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO/DIS 10993-9:2018); German and English version prEN ISO 10993-9:2018
  • DIN EN ISO 10993-7/A1:2018 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1 (ISO 10993-7:2008/DAM 1:2018); German and English version EN ISO 10993-7:2008/prA1:2018
  • DIN EN ISO 10993-15:2023-07 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys (ISO 10993-15:2019); German version EN ISO 10993-15:2023
  • DIN EN ISO 10993-15:2018 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys (ISO/DIS 10993-15:2018); German and English version prEN ISO 10993-15:2018
  • DIN EN ISO 10993-13:2010-11 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010); German version EN ISO 10993-13:2010
  • DIN EN ISO 10993-16:2018 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017)

Professional Standard - Medicine, biological evaluation

  • YY/T 0127.11-2014 Biological evaluation of medical devices used in dentistry.Part 11:Pulp capping test
  • YY/T 0616-2007 Medical gloves for single use.Requirements and testing for biological evaluation
  • YY/T 1912-2023 Biological evaluation and testing of medical devices for soft tissue regeneration
  • YY/T 1295-2015 Biological evaluation of medical devices.Nanomaterial: Endotoxin test
  • YY/T 0268-2008 Dentistry.Biological evaluation of medical devices used in dentistry.Part 1:Evaluation and test
  • YY/T 0127.5-2014 Biological evaluation of medical devices used in dentistry.Part 5:Inhalation toxicity test
  • YY/T 0127.3-2014 Biological evaluation of medical devices used in dentistry.Part 3: Endodontic usage test
  • YY/T 0616.1-2016 Medical gloves for single use.Part 1:Requirements and testing for biological evaluation
  • YY 0719.7-2011 Ophthalmic optics.Contact lens care products.Part 7:Biological evaluation test methods
  • YY/T 0127.4-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method Bone implant test
  • YY/T 0127.12-2008 Dentistry.Biological evaluation of medical devices used in dentistry Part 2:Test method.Micronucleus test
  • YY/T 0127.18-2016 Biological evaluation of medical devices used in dentistry.Part 18:Dentine barrier cytotoxicity test
  • YY/T 0127.4-1998 Biological evaluation of dental materials.Unit2:Biological evaluation method of dental materials.Bone implant test
  • YY/T 0127.13-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method.Oral mucous membrane irritation test
  • YY/T 0127.5-1999 Biological evaluation of dental materials.Unit 2:Biological test methods of dental materials.Inhalation toxicity test
  • YY/T 0127.6-1999 Biological evaluation of dental materials.Unit 2:Biological test methods of dental materials.Dominant lethal test
  • YY/T 0127.8-2001 Biological evaluation of dental materials.Part 2:Biological evaluation test method of dental materials.Subcutaneous implant test
  • YY/T 0127.3-1998 Biological evaluation of dental materials.Unit 2:Biological evaluation method of dental materials。Endodontic usage test
  • YY/T 0993-2015 Biological evaluation of medical devices.Nanomaterial: In vitro cytotoxicity tests (MTT assay and LDH assay)
  • YY/T 1897-2023 Biological evaluation of nanomedical devices Genotoxicity test In vitro mammalian cell micronucleus test
  • YY/T 1815-2022
  • YY/T 0127.17-2014 Biological evaluation of medical devices used in dentistry.Part 17: Mouse lymphoma cells (TK) gene mutation test
  • YY/T 0127.14-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method.Acute oral toxicity test
  • YY/T 0127.7-2001 Biological evaluation of of dental materials.Part 2:Biological evaluation test method of dental materials.Pulp and dentine usage test
  • YY/T 0127.2-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method.Acute systemic toxicity:intravenous path
  • YY/T 0127.16-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method In Vitro mammalian chromosome aberration test

European Committee for Standardization (CEN), biological evaluation

  • EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:1995 Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity (ISO 10993-11 : 1993)
  • EN ISO 10993-8:2000 Biological Evaluation of Medical Devices - Part 8: Selection and Qualification of Reference Materials for Biological Tests ISO 10993-8:2000
  • EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • EN 15354:2022 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • EN 12929-2:2015+A1:2022 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • EN ISO 11930:2019/A1:2022 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product - Amendment 1 (ISO 11930:2019/Amd 1:2022)
  • FprEN ISO 10993-10:2021 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO/FDIS 10993-10:2021)
  • EN ISO 10993-18:2020/prA1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021)
  • EN ISO 10993-6:2016 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • CEN EN ISO 10993-12:2004 Biological Evaluation of Medical Devices - Part 12: Sample Preparation and Reference Materials ISO 10993-12:2002
  • EN 30993-6:1994 Biological Evaluation of Medical Devices - Part 6: Tests for Local Effects After Implantation (ISO 10993-6 : 1994)
  • FprEN ISO 10993-17 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/FDIS 10993-17:2023)
  • EN 30993-4:1993 Biological Evaluation of Medical Devices - Part 4: Selection of Tests for Interactions with Blood (ISO 10993-4 : 1992)
  • EN ISO 10993-15:2023 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys (ISO 10993-15:2019)
  • FprEN ISO 10993-15 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys (ISO/FDIS 10993-15:2019)

IT-UNI, biological evaluation

  • UNI EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • UNI EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • UNI EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • UNI EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process

国家市场监督管理总局、中国国家标准化管理委员会, biological evaluation

  • GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity
  • GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation
  • GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
  • GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood
  • GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables

ES-UNE, biological evaluation

  • UNE-EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • UNE-EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
  • UNE-EN ISO 10993-12:2022 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • UNE-EN ISO 10993-2:2023 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • UNE-EN ISO 10993-10:2023 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021)
  • UNE-EN ISO 10993-4:2018 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017)
  • UNE-EN ISO 10993-7:2009/AC:2010 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Technical Corrigendum 1 (ISO 10993-7:2008/Cor 1:2009)
  • UNE-EN ISO 10993-16:2018 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017)

PH-BPS, biological evaluation

  • PNS ISO 10993-2:2021 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • PNS ISO 10993-11:2021 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • PNS ISO 10993-5:2021 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • PNS ISO 10993-7:2021 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • PNS ISO 10993-10:2021 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization
  • PNS ISO 10993-6:2021 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • PNS ISO 10993-4:2021 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood
  • PNS ISO 10993-3:2021 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • PNS ISO 10993-9:2021 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products

RU-GOST R, biological evaluation

  • GOST ISO 10993-1-2011 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing
  • GOST ISO 10993-12-2015 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • GOST ISO 10993-11-2011 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic toxicity
  • GOST R ISO 10993-11-1999 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic to xicity
  • GOST ISO 10993-18-2011 Medical devices. Biological evaluation of medical devices. Part 18. Chemical characterization of materials
  • GOST R ISO 10993-10-1999 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and sensitization
  • GOST ISO 10993-5-2011 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
  • GOST ISO 10993-7-2016 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST R ISO 10993.7-1999 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-7-2011 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST R ISO 10993-12-1999 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • GOST ISO 10993-6-2011 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST ISO 10993-12-2011 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and control materials
  • GOST R ISO 10993-6-1999 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods
  • GOST ISO 10993-10-2011 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and delayed-type hypersensitivity
  • GOST ISO 10993-17-2011 Medical devices. Biological evaluation of medical devices. Part 17. Establishment of allowable limits for leachable substances
  • GOST ISO 10993-14-2011 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST R ISO 10993.4-1999 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST R ISO 10993-14-2001 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST ISO 10993-4-2011 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST ISO 10993-9-2011 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • GOST ISO 10993-3-2011 Medical devices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GOST ISO/TS 10993-19-2011 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials
  • GOST ISO 10993-9-2015 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • GOST R ISO 10993.1-1999 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing / Note: To be replaced by GOST R ISO 10993-1 (2009).
  • GOST ISO 10993-16-2016 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-15-2011 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
  • GOST R ISO 10993-15-2001 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
  • GOST ISO 10993-13-2011 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
  • GOST ISO 10993-16-2011 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST R ISO 10993.16-1999 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-13-2016 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices

RO-ASRO, biological evaluation

  • STAS SR EN 30993-1-1996 Biological evaluation of medical devices -Part 1: Guidance on selection of tests
  • STAS SR EN 30993-3-1996 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenity and reproductive toxicity
  • STAS SR EN 30993-5-1996 Biological evaluation of medical devices -Part 5: Tests for cytotoxicity: in vitro methods

American National Standards Institute (ANSI), biological evaluation

  • ANSI/AAMI/ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • BS EN ISO 10993-15:2023 Biological evaluation of medical devices Identification and quantification of degradation products from metals and alloys (British Standard)

CH-SNV, biological evaluation

  • SN EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • SN EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • SN EN ISO 10993-9:2021 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)

Lithuanian Standards Office , biological evaluation

  • LST EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • LST EN 455-3-2007 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation
  • LST EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • LST EN ISO 10993-10:2013 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization (ISO 10993-10:2010)
  • LST EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)

PL-PKN, biological evaluation

  • PN-EN ISO 10993-23-2021-08 E Biological evaluation of medical devices -- Part 23: Tests for irritation (ISO 10993-23:2021)
  • PN-EN ISO 10993-1-2021-06 E Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)

中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会, biological evaluation

  • GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization
  • GB/T 16886.12-2017 Biological evaluation of medical devices—Part 12:Sample preparation and reference materials
  • GB/T 16886.9-2017 Biological evaluation of medical devices—Part 9: Framework for identification and quantification of potential degradation products
  • GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices

AENOR, biological evaluation

  • UNE-EN ISO 10993-2:2007 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2006)
  • UNE-EN 455-3:2015 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation
  • UNE-EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2006)
  • UNE-EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • UNE-EN ISO 10993-7:2009 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008)
  • UNE-EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
  • UNE-EN ISO 10993-10:2013 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization (ISO 10993-10:2010)
  • UNE-EN ISO 10993-12:2013 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2012)
  • UNE-EN ISO 10993-6:2017 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016)
  • UNE-EN ISO 10993-1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2009)
  • UNE-EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001)
  • UNE-EN ISO 10993-17:2009 Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002)
  • UNE-EN ISO 10993-3:2015 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014)
  • UNE-EN ISO 10993-4:2017 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017)
  • UNE-EN ISO 10993-9:2010 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2009)
  • UNE-EN ISO 10993-15:2009 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys (ISO 10993-15:2000)
  • UNE-EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
  • UNE-EN ISO 10993-16:2010 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2010)

国家药监局, biological evaluation

  • YY/T 1775.1-2021 Biological Evaluation of Absorbable Medical Devices Part 1: Guidelines for Absorbable Implants

GOSTR, biological evaluation

  • GOST ISO/TR 10993-22-2020 Medical devices. Biological evaluation of medical devices. Part 22. Guidance on nanomaterials
  • GOST ISO/TR 10993-33-2018 Medical levices. Biological evaluation of medical devices. Part 33. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • GOST ISO 10993-4-2020 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST ISO 10993-3-2018 Medical levices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicit
  • GOST R ISO 10993-2-2009 Standardization in the Russian Federation. Medical devices. Biological evaluation of medical devices. Part 2. Animal welfare requirements

Malaysia Standards, biological evaluation

  • MS 1497-2000 Methods of biological evaluation of the efficacy of repellent-bioassay method for mosquito repellent on human skin

BE-NBN, biological evaluation

  • NBN EN 30993-6-1995 Biological evaluation of medical devices - Part 6 : Tests for local effects after implantation (ISO 10993-6:1994)

AT-ON, biological evaluation

  • OENORM EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • OENORM EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)
  • OENORM EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)

Canadian Standards Association (CSA), biological evaluation

  • CSA ISO 10993-9-00-CAN/CSA:2000 Biological Evaluation of Medical Devices - Part 9: Framework for Identification and Quantification of Potential Degradation Products Second Edition; ISO 10993-9: 1999




Copyright ©2007-2023 ANTPEDIA, All Rights Reserved